NCT02182609View on ClinicalTrials.gov

99mTc-rhAnnexin V-128: a First In Man Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

August 31, 2015

Conditions
Healthy Adult Volunteers
Interventions
DRUG

Kit for the Preparation of 99mTc-rhAnnexin V-128

Kit for the Preparation of Tc-99m Recombinant Human Annexin V-128 for Injection

Trial Locations (1)

ON K1Y 4W7

The University of Ottawa Heart Institute, Ottawa

Sponsors
All Listed Sponsors
collaborator

Atreus Pharmaceuticals Corporation

INDUSTRY

lead

Advanced Accelerator Applications

INDUSTRY